Overview of Dr. Scandura
Dr. Joseph Scandura is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, New York-Presbyterian Hospital, New York-Presbyterian Hospital, and NewYork-Presbyterian/Columbia University Irving Medical Center. She received her medical degree from Lewis Katz School of Medicine at Temple University and has been in practice 20 years. Dr. Scandura accepts several types of health insurance, listed below. She is one of 375 doctors at New York-Presbyterian Hospital and one of 118 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Oncology. She has more than 60 publications and over 500 citings.
Office
525 E 68th St
St341
New York, NY 10065
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1999 - 2003
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1997 - 1999
- Lewis Katz School of Medicine at Temple UniversityClass of 1997
Certifications & Licensure
- NY State Medical License 1999 - 2024
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
Clinical Trials
- Phase I Epigenetic Priming Using Decitabine With Induction Chemotherapy in AML Start of enrollment: 2007 Jul 01
- Decitabine, Cytarabine, and Daunorubicin Hydrochloride in Treating Patients With Acute Myeloid Leukemia Start of enrollment: 2011 Sep 16
Publications & Presentations
PubMed
- Transplant Outcomes in Myelofibrosis: Impact of Donor Type (Cord Blood Grafts Supported by CD34+ selected Cells [Haplo-Cord] Versus Matched Donors).Nima Ghalehsari, Franco Castillo Tokumori, Zhengming Chen, Marie Liu, Sebastian A Mayer
Transplantation and Cellular Therapy. 2024-11-01 - JAK2impairs lymphoid differentiation in myeloproliferative neoplasms.Daniel C Choi, Nassima Messali, Narasimha Rao Uda, Ghaith Abu-Zeinah, Pouneh Kermani
Leukemia. 2024-11-01 - 1 citationsAre thrombosis, progression, and survival in ET predictable?Ghaith Abu-Zeinah, Katie Erdos, Neville Lee, Ahamed Lebbe, Imane Bouhali
Blood Cancer Journal. 2024-06-25
Abstracts/Posters
- Low-Dose Epo after Tgf_ Blockade Triggers Robust Erythropoiesis and Increased RBC Production.Joseph Scandura, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Recombinant Interferon-_ Reduces Thrombotic Events in Patients with Polycythemia VeraJoseph Scandura, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Interferon in Polycythemia Vera (PV) Yields Improved Myelofibrosis-Free and Overall SurvivalJoseph Scandura, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
- Weill Cornell Team Creates Self-Renewing Hematopoietic Stem Cells for TransplantationMay 17th, 2017
- New Method of Creating Blood Vessel Cells to Repair Injured TissuesJanuary 20th, 2017
- Are You a Patient Taking Vidaza or Dacogen?February 8th, 2016
- Join now to see all
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS California CaliforniaCare HMO
BCBS California PowerSelect HMO
BCBS California PPO
Blue Shield CA Local Access Plus HMO
Blue Shield California HMO
Blue Shield California PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMOEmpire BCBS PPO
GHI PPO
Great West PPO
Health Net California Large Group PPO
Health Net HMO - Employer Group
HIP of New York - Select PPO
Humana ChoiceCare Network PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
Pacificare HMO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: